Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 6 Issue 5, May 2006

From The Editors

Top of page ⤴

Research Highlight

Top of page ⤴

In the News

Top of page ⤴

Research Highlight

Top of page ⤴

In Brief

Top of page ⤴

Research Highlight

Top of page ⤴

Trial Watch

Top of page ⤴

Research Highlight

Top of page ⤴

Review Article

  • Both oestrogen and selective oestrogen receptor modulators can promote endometrial carcinogenesis. However, gene-expression studies have shown that they function through distinct, albeit overlapping, mechanisms. This article reviews our current understanding of both pathways.

    • Yongfeng Shang
    Review Article
  • Several ubiquitin ligases are altered in cancer. These proteins are crucial for the ubiquitin-mediated degradation of cell-cycle proteins, ensuring regulated progression through the cycle. Understanding the mechanistic roles of these ligases is therefore of great importance.

    • Keiichi I. Nakayama
    • Keiko Nakayama
    Review Article
  • BRCA1 interacts with many proteins, but one particular protein, BARD1, seems to be an important regulator of BRCA1 function. This review examines whether BARD1 has BRCA1-independent functions that contribute to the pathogenesis of cancer.

    • Irmgard Irminger-Finger
    • Charles Edward Jefford
    Review Article
  • Fibroblasts are an important component of the tumour microenvironment. They become activated in tumours, as they do in healing wounds. Here, their roles in tumour initiation, progression and metastasis are reviewed.

    • Raghu Kalluri
    • Michael Zeisberg

    Collection:

    Review Article
Top of page ⤴

Opinion

  • Recent data indicate that growth-factor receptors and associated adaptors can accumulate in the nucleus. Are there novel functions for these proteins that might change our understanding of their role in cancer, and do these findings have implications for drug resistance?

    • Charles Massie
    • Ian G. Mills
    Opinion
Top of page ⤴

Erratum

Top of page ⤴

Search

Quick links